Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Receivables (2023 - 2025)

Vsee Health filings provide 3 years of Receivables readings, the most recent being $2.8 million for Q4 2025.

  • On a quarterly basis, Receivables rose 25.69% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a 25.69% increase, with the full-year FY2025 number at $2.8 million, up 25.69% from a year prior.
  • Receivables hit $2.8 million in Q4 2025 for Vsee Health, down from $2.9 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $2.9 million in Q3 2025 to a low of $603480.0 in Q4 2023.
  • Median Receivables over the past 3 years was $2.0 million (2025), compared with a mean of $2.0 million.
  • Biggest five-year swings in Receivables: soared 272.51% in 2024 and later rose 16.8% in 2025.
  • Vsee Health's Receivables stood at $603480.0 in 2023, then soared by 272.51% to $2.2 million in 2024, then rose by 25.69% to $2.8 million in 2025.
  • The last three reported values for Receivables were $2.8 million (Q4 2025), $2.9 million (Q3 2025), and $1.9 million (Q2 2025) per Business Quant data.